Benzo[a]pyrene diol epoxide stimulates an inflammatory response in normal human lung fibroblasts through a p53 and JNK mediated pathway.
Cellular responses to carcinogens are typically studied in transformed cell lines, which do not reflect the physiological status of normal tissues. To address this question, we have characterized the transcriptional program and cellular responses of human lung WI-38 fibroblasts upon exposure to the ultimate carcinogen benzo[a]pyrene diol epoxide (BPDE). In contrast to observations in cell lines, we find that BPDE treatment induces a strong inflammatory response in these normal fibroblasts. Whole-genome microarrays show induction of numerous inflammatory factors, including genes that encode interleukins (ILs), growth factors and enzymes related to prostaglandin synthesis and signaling. Real-time reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) revealed a time- and dose-dependent-induced expression and production of cyclooxygenase 2, prostglandin E2 and IL1B, IL6 and IL8. In parallel, cell cycle progression and DNA repair processes were repressed, but DNA damage signaling was increased via p53-Ser15 phosphorylation and induced expression levels of GADD45A, CDKN1A, BTG2 and SESN1. Network analysis suggested that activator protein 1 transcription factors may link the cell cycle response and DNA damage signaling with the inflammatory stress-response in these cells. We confirmed this hypothesis by showing that p53-dependent signaling through c-jun N-terminal kinase (JNK) led to increased cJun-Ser63 phosphorylation and that inhibition of JNK-mediated cJun activation using p53- or JNK-specific inhibitors significantly reduced IL gene expression and subsequent production of IL8. This is the first demonstration that a strong inflammatory response is triggered in normal fibroblasts by BPDE and that this occurs through coordinated regulation with other cellular processes.
Dreij
Kristian
K
Department of Biology, New York University, 1009 Silver Center, 100 Washington Square East, New York, NY 10003, USA.
Rhrissorrakrai
Kahn
K
Gunsalus
Kristin C
KC
Geacintov
Nicholas E
NE
Scicchitano
David A
DA
D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D048670:MAP Kinase Kinase 4 / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D016159:Tumor Suppressor Protein p53; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D048670:MAP Kinase Kinase 4
Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L981-91
15234907
Mutat Res. 2004 May 18;549(1-2):43-64
15120962
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
15285078
J Natl Cancer Inst. 2002 Feb 20;94(4):252-66
11854387
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
7568133
Toxicol In Vitro. 2008 Mar;22(2):411-21
18494146
Toxicol Lett. 1982 Jan;10(1):109-18
7080063
Chem Res Toxicol. 2005 Apr;18(4):655-64
15833025
Toxicol Appl Pharmacol. 2008 Oct 15;232(2):309-16
18671994
Cell Cycle. 2007 Jul 15;6(14):1753-61
17630511
Science. 1999 Sep 10;285(5434):1733-7
10481009
Free Radic Biol Med. 2005 Nov 1;39(9):1177-83
16214033
J Environ Pathol Toxicol Oncol. 2007;26(4):281-94
18197826
J Leukoc Biol. 1999 Mar;65(3):291-8
10080530
Mutat Res. 2000 Nov 20;471(1-2):57-70
11080661
Carcinogenesis. 1999 May;20(5):859-65
10334204
Biostatistics. 2003 Apr;4(2):249-64
12925520
Genome Biol. 2003;4(1):R7
12540299
Cell. 2005 Feb 25;120(4):513-22
15734683
Mol Carcinog. 2007 Jan;46(1):32-41
16921490
Cancer Lett. 2007 Oct 28;256(2):137-65
17629396
BMC Bioinformatics. 2006 Jan 31;7:49
16448562
Science. 1998 Sep 11;281(5383):1674-7
9733514
Nature. 1974 Nov 22;252(5481):326-8
4473724
J Med Chem. 2006 Jun 15;49(12):3563-80
16759099
Cell Mol Life Sci. 2009 Mar;66(6):994-1009
19153657
Cancer Res. 2002 Sep 15;62(18):5288-94
12234998
Chem Res Toxicol. 2007 Dec;20(12):1797-810
17944540
Biol Pharm Bull. 2005 Jul;28(7):1244-8
15997107
Carcinogenesis. 2003 Feb;24(2):225-34
12584171
J Biol Chem. 2006 Jul 21;281(29):19906-15
16679317
Toxicol Lett. 2008 Mar 15;177(2):130-7
18289803
PLoS Biol. 2008 Dec 2;6(12):2853-68
19053174
Cancer Cell. 2004 Sep;6(3):203-8
15380510
Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57
1751545
Free Radic Biol Med. 2007 Jun 15;42(12):1858-65
17512465
Mol Cancer Ther. 2005 Sep;4(9):1369-77
16170029
Genes Dev. 1999 Jan 15;13(2):152-7
9925639
Environ Mol Mutagen. 2000;36(3):201-5
11044901
Clin Immunol. 2003 Apr;107(1):10-9
12738245
Oncogene. 2003 May 15;22(19):2993-3006
12771951
DNA Repair (Amst). 2008 Aug 2;7(8):1202-12
18479980
Genomics. 2009 Apr;93(4):332-42
19150397
Chem Biol Interact. 2002 Sep 20;141(1-2):77-95
12213386
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6846-51
18474869
Br Med J. 1977 Jun 25;1(6077):1645-8
871704
Methods. 2001 Dec;25(4):402-8
11846609
Biol Proced Online. 2006;8:1-10
16446781
Toxicol Lett. 2004 Jul 15;151(2):345-55
15183459
Cancer Cell. 2007 Jun;11(6):555-69
17560336
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
10413421
Chem Res Toxicol. 2005 Apr;18(4):619-29
15833022
Carcinogenesis. 2008 Jan;29(1):202-10
17942461
Toxicol Lett. 2006 Aug 20;165(2):182-94
16713138
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238